When did Insulet report Q2 2025 earnings?

Insulet (PODD) reported Q2 2025 earnings on August 7, 2025 before market open.

What were Insulet's Q2 2025 revenue and EPS?

Insulet reported revenue of $649.1M and eps of $1.17 for Q2 2025.

Did Insulet beat estimates in Q2 2025?

Revenue beat the consensus estimate of $614.2M by $34.9M. EPS beat the consensus estimate of $0.92 by $0.25.

How did Insulet's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 32.9% from $488.5M a year earlier and eps grew 112.7% from $0.55.

Where can I find Insulet's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001145197-25-000038) directly on SEC EDGAR. The filing index links above go to sec.gov.

Insulet PODD Q2 2025 earnings

Reported August 7, 2025 · Before market open

Revenue$649.1MBeat by $34.9M

EPS$1.17Beat by $0.25

Revenue estimate$614.2M

EPS estimate$0.92

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$787.4M

EPS estimate$1.45

Financials

Q2 2025

Income statement

See full

Revenue$649.1M+32.9%

Gross profit$452.2M+36.7%

Operating income$121.1M+122%

Net income$22.5M-88.1%

EPS (diluted)$0.32-87.6%

Balance sheet

See full

Cash & equivalents$1.1B+36.6%

Total debt$1.9B+26.7%

Total equity$1.5B+46.5%

Total assets$3.5B+20.4%

Cash flow

See full

Operating cash flow$196.5M+126%

CapEx$18.6M-17.3%

Free cash flow$177.9M+177%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$21.88B+55.0%

Enterprise value$22.62B+53.2%

P/E92.7×+57.0×

P/S9.3×+1.7×

Profitability

See full

Gross margin70.7%+1.7pp

Operating margin17.3%+2.7pp

Net margin10%-11.1pp

FCF margin17.2%+7.5pp

Returns & leverage

See full

Return on equity19.2%-31.7pp

Debt / equity1.3×-0.2×

Current ratio2.3×-1.3×

Segments

By product

See full

Total Omnipod products$639.0M+33.0%

International$185.8M+44.9%

Drug Delivery$10.2M+25.9%

Versus estimates

Revenue

Q1 2026$761.7MBeat by $31.8M Q4 2025$783.8MBeat by $14.8M Q3 2025$706.3MBeat by $27.9M

Q2 2025$649.1MBeat by $34.9M

Q1 2025$569.0MBeat by $25.7M Q4 2024$597.5MBeat by $15.0M

Diluted EPS

Q1 2026$1.42Beat by $0.23 Q4 2025$1.55Beat by $0.08 Q3 2025$1.24Beat by $0.10

Q2 2025$1.17Beat by $0.25

Q1 2025$1.02Beat by $0.23 Q4 2024$1.15Beat by $0.15

Ask the moment Insulet reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Insulet report Q2 2025 earnings?: Insulet (PODD) reported Q2 2025 earnings on August 7, 2025 before market open.
What were Insulet's Q2 2025 revenue and EPS?: Insulet reported revenue of $649.1M and eps of $1.17 for Q2 2025.
Did Insulet beat estimates in Q2 2025?: Revenue beat the consensus estimate of $614.2M by $34.9M. EPS beat the consensus estimate of $0.92 by $0.25.
How did Insulet's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 32.9% from $488.5M a year earlier and eps grew 112.7% from $0.55.
Where can I find Insulet's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001145197-25-000038) directly on SEC EDGAR. The filing index links above go to sec.gov.